Skip to main content

Table 4 Ciprofibrate treatment increases LDL- and decreases HDL- cholesterol plasma removal. Relative 3H-cholesteryl ether distribution (%) in plasma lipoproteins six hours after the injection of 3H-HDL into ciprofibrate treated or control CETP transgenic mice.

From: Ciprofibrate increases cholesteryl ester transfer protein gene expression and the indirect reverse cholesterol transport to the liver

Groups

VLDL

LDL

HDL

control

(n = 5)

6.4 ± 1.8

18.3 ± 3.9

75.2 ± 4.6

treated

(n = 5)

5.2 ± 1.7

7.9 ± 1.8b

86.9 ± 6.4a

  1. Mean ± SD. Plasma samples were fractionated by FPLC. Treated vs. control a p < 0.05; b p < 0.005.
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X